MIMunaza Ijaz

Munaza Ijaz

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Munaza Ijaz has a total of 14 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Integration of traditional medicinal plants with polymeric nanofibers for wound healing

    by Badriyah Shadid Alotaibi, Haya Khader Ahmad Yasin, Abida Kalsoom Khan, Mizna Javed, Munaza Ijaz

    Chronic wounds pose a significant healthcare challenge, necessitating innovative approaches for improved healing. Traditional medicinal plants have long been used for wound care, and recent advancements in nanotechnology offer new possibilities for enhancing their therapeutic effects. Electrospun nanofibers provide an efficient drug delivery system, improving the bioavailability and stability of bioactive compounds. This review explores the integration of phytochemical-loaded nanofibers for wound healing, highlighting their potential in treating various wounds, including burns, diabetic ulcers, and surgical wounds. Additionally, it discusses the medicinal value of traditional plants, their role in wound care, and the future prospects of combining nanotechnology with artificial intelligence for personalized treatment.


  • Open Access

    Evaluation and Molecular Characterization of Colistin-Resistant Isolates of Pseudomonas aeruginosa and Klebsiella pneumoniae from the Infected Wounds of Hospitalized Patients

    by Munaza Ijaz, Madiha Khan, Haya Yasin

    Munaza Ijaz, Madiha Khan , and Haya Yasin. J. Microbiol. Biotechnol. 2024;34:1-7. https://doi.org/10.4014/jmb.2407.07005


  • Open Access

    In Vivo Wound Healing Potential and Molecular Pathways of Amniotic Fluid and Moringa Olifera-Loaded Nanoclay Films

    by Akram Ashames, Munaza Ijaz, Manal Buabeid, Haya Yasin, Sidra Yaseen, Richie R. Bhandare, Ghulam Murtaza

    Cutaneous wounds pose a significant health burden, affecting millions of individuals annually and placing strain on healthcare systems and society. Nanofilm biomaterials have emerged as promising interfaces between materials and biology, offering potential for various biomedical applications. To explore this potential, our study aimed to assess the wound healing efficacy of amniotic fluid and Moringa olifera-loaded nanoclay films by using in vivo models. Additionally, we investigated the antioxidant and antibacterial properties of these films. Using a burn wound healing model on rabbits, both infected and non-infected wounds were treated with the nanoclay films for a duration of twenty-one days on by following protocols approved by the Animal Ethics Committee. We evaluated wound contraction, proinflammatory mediators, and growth factors levels by analyzing blood samples. Histopathological changes and skin integrity were assessed through H&E staining. Statistical analysis was performed using SPSS software (version 2; Chicago, IL, USA) with significance set at p < 0.05. Our findings demonstrated a significant dose-dependent increase in wound contraction in the 2%, 4%, and 8% AMF-Me.mo treatment groups throughout the study (p < 0.001). Moreover, macroscopic analysis revealed comparable effects (p > 0.05) between the 8% AMF-Me.mo treatment group and the standard treatment. Histopathological examination confirmed the preservation of skin architecture and complete epidermal closure in both infected and non-infected wounds treated with AMF-Me.mo-loaded nanofilms. RT-PCR analysis revealed elevated concentrations of matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF), along with decreased levels of tumor necrosis factor-alpha (TNF-α) in AMF-Me.mo-loaded nanofilm treatment groups. Additionally, the antimicrobial activity of AMF-Me.mo-loaded nanofilms contributed to the decontamination of the wound site, positioning them as potential candidates for effective wound healing. However, further extensive clinical trials-based studies are necessary to confirm these findings.


  • Top Cited Papers
    Open Access

    Nanocarriers-Mediated Drug Delivery Systems for Anticancer Agents: An Overview and Perspectives

    by Zehra Edis, Junli Wang, Muhammad Khurram Waqas, Muhammad Ijaz, Munazza Ijaz

    Nanotechnology has been actively integrated as drug carriers over the last few years to treat various cancers. The main hurdle in the clinical management of cancer is the development of multidrug resistance against chemotherapeutic agents. To overcome the limitations of chemotherapy, the researchers have been developing technological advances for significant progress in the oncotherapy by enabling the delivery of chemotherapeutic agents at increased drug content levels to the targeted spots. Several nano-drug delivery systems designed for tumor-targeting are evaluated in preclinical and clinical trials and showed promising outcomes in cancerous tumors’ clinical management. This review describes nanocarrier’s importance in managing different types of cancers and emphasizing nanocarriers for drug delivery and cancer nanotherapeutics. It also highlights the recent advances in nanocarriers-based delivery systems, including polymeric nanocarriers, micelles, nanotubes, dendrimers, magnetic nanoparticles, solid lipid nanoparticles, and quantum dots (QDs). The nanocarrier-based composites are discussed in terms of their structure, characteristics, and therapeutic applications in oncology. To conclude, the challenges and future exploration opportunities of nanocarriers in chemotherapeutics are also presented.